Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Lorundrostat may expand treatment toolbox for uncontrolled hypertension
29 Sep 2023
bởiJairia Dela Cruz
Aldosterone synthase inhibition with lorundrostat confers substantial blood pressure (BP)-lowering benefit in people with uncontrolled hypertension, while having a favourable safety profile, according to data from the phase II Target-HTN trial.
Lorundrostat may expand treatment toolbox for uncontrolled hypertension
29 Sep 2023Pretreatment serum CEA level predicts survival in NSCLC
29 Sep 2023
Pretreatment level of serum carcinoembryonic antigen (CEA) is independently associated with overall and disease-free survival among patients with nonsmall cell lung cancer (NSCLC), reports a study. The same marker is also used for the prognosis of patients with the same pathologic stages.